25 mg/6 mg/120 mcg
Chewable Tablet
Antiparasitic
(Anthelmintic/Ectoparasiticide for Systemic Use)
For Dogs And Puppies - 8 weeks of age and older
Indications: (Pyrantel + Sarolaner +Moxidectin) SIMPARICA TRIO prevents heartworm disease caused by Dirofilaria immitis, kills adult fleas (Ctenocephalides felis) and is indicated for the treatment and prevention of flea infestations, the treatment and control of tick infestations with Amblyomma americanum (lone star tick), Amblyomma maculatum (Gulf Coast tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), and the treatment and control of the roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina) and adult hookworm (Ancylostoma caninum and Uncinaria stenocephala) infections for one month in dogs and puppies 8 weeks of age and older, and weighing more than 1.2 kg.
Dosage and Administration: (Pyrantel + Sarolaner + Moxidectin) SIMPARICA TRIO is given orally once a month, at the recommended minimum dose of 5 mg/kg Pyrantel, 1.2mg.kg Sarolaner, 24 mcg/kg Moxidectin
Warnings: Not for use in humans. Keep this and all drugs out of reach of children.
Keep (Pyrantel + Sarolaner + Moxidectin) SIMPARICA TRIO in a secure location out of reach of dogs, cats and other animals to prevent accidental ingestion or overdose.
Precautions: Sarolaner, one of the ingredients in (Pyrantel + Sarolaner + Moxidectin) SIMPARICA TRIO, is a member of the isoxazoline class, This class has been associated with neurologic adverse recations including tremors, ataxia, and siezures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of siezures. Use with caution in dogs with a history of siezures or neurologic disorders. The safe use of (Pyrantel + Sarolaner + Moxidectin) SIMPARICA TRIO has not been evaluated in breeding, pregnant, or lactating dogs.
Storage Condition: Store at temperature not exceeding 30 C. For suspected adverse drug reaction, report to the FDA: www.fda.gov.ph